SK Chem Strikes Korea Sanofi Vaccine Deal
This article was originally published in PharmAsia News
Executive Summary
In an ongoing effort to boost its vaccine portfolio, SK Chemicals has reached a strategic alliance with Sanofi Pasteur, the vaccine division of Sanofi, to begin marketing in South Korea Sanofi's Menactra, a meningococcal conjugate vaccine, and a live-attenuated Japanese encephalitis vaccine.